Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for ADHD in Adults
NCT03062839Phase 3Unknown
- Sponsor
- Hospital Israelita Albert Einstein
- Start
- Sep 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in attention deficit hyperactivity disorder (ADHD), sponsored by Hospital Israelita Albert Einstein. Status: unknown.
02
Drugs
melatonin
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT03062839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03062839.